Broccoli sprout supplementation in patients with advanced pancreatic cancer is difficult despite positive effects-results from the POUDER pilot study.
- 2019-06-27
- Clinical Trial · n = 40
- Investigational new drugs 38(3)
- Vladimir J Lozanovski
- Georgios Polychronidis
- Wolfgang Gross
- Negin Gharabaghi
- Arianeb Mehrabi
- Thilo Hackert
- Peter Schemmer
- Ingrid Herr
- PubMed: 31250356
- DOI: 10.1007/s10637-019-00826-z
- High evidence
- Clinical
broccoli sprouts sometimes increased digestive problems, nausea and emesis
- Effect
- Harmful
- Effect size
- Small
- Significant
- No
- Dose
- 15 capsules daily (90 mg sulforaphane, 180 mg glucoraphanin)